Printed from Voxsanity (voxsanity.com.au) — NCT07083375 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Lung Cancer
Phase 2 Lung Cancer Trial, Not Yet Recruiting
NCT07083375
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have signed a consent form and are willing to follow the study procedures.
- People aged 18 years or older.
- People with an estimated life expectancy of at least 3 months.
- People with a good general level of physical functioning (rated 0 or 1 on a standard scale used by doctors to measure how cancer affects daily activities).
- People who have been diagnosed with extensive-stage small cell lung cancer (a type of lung cancer that has spread) confirmed by a tissue or cell sample, and who have not yet received any treatment for it.
- People who are willing to provide a stored or fresh tumour tissue sample, though enrolment may still be possible if a sample is not available, based on the doctor's assessment.
- People who have at least one tumour that can be measured using standard imaging criteria.
- People who fully understand the study and choose to take part voluntarily.
- People whose blood and organ function results meet all of the following levels (as tested by a doctor):
- White blood cell count (neutrophils) of at least 1.5 × 10⁹/L
- Platelet count of at least 100 × 10⁹/L
- Haemoglobin (red blood cell measure) of at least 90 g/L, without a blood transfusion in the past 14 days
- Kidney function within an acceptable range, based on a blood test or urine measurement
- Liver enzyme levels within acceptable limits, with slightly higher limits allowed if cancer has spread to the liver
- Bilirubin (a liver-related substance) within acceptable limits, with an exception for people with a condition called Gilbert's syndrome
- Thyroid hormone levels within 10% of the normal range
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously received chemotherapy, immunotherapy, targeted therapy, or radiotherapy.
- People whose tissue or cell samples show a different type of lung cancer, such as non-small cell lung cancer or a mixed type.
- People who have brain metastases (cancer that has spread to the brain) causing symptoms, or cancer spreading along the lining of the brain or spinal cord.
- People with an active or suspected autoimmune disease (where the immune system attacks the body), except for certain stable or manageable conditions such as vitiligo, type 1 diabetes, or hypothyroidism managed only with hormone replacement.
- People with a current or past active tuberculosis (TB) infection, including those who were treated for TB within the past year.
- People who need to take corticosteroids or other medicines that suppress the immune system on an ongoing basis.
- People who are pregnant or breastfeeding.
- People who have significant lung disease involving inflammation of lung tissue, or suspected lung damage caused by medication.
- People who test positive for HIV, or who have active hepatitis B or hepatitis C infections (as determined by specific blood test results).
- People with a significant history of neurological or psychiatric conditions, such as dementia, depression, epilepsy, or bipolar disorder.
- People who have taken part in another clinical drug trial within 4 weeks before being enrolled in this study.
- People who have used anti-tumour traditional Chinese medicine within 2 weeks before the first study treatment.
- People who have had another type of cancer within the past 2 years, except for certain skin cancers or early-stage cancers that have been fully treated and cured.
- People with serious heart or blood vessel conditions, such as significant heart failure, a heart attack, or a stroke within the past 6 months.
- People who have had a blood clot in a vein or artery (such as a deep vein thrombosis or pulmonary embolism) within the past 6 months, unless it was related to a catheter.
- People who have received a live vaccine within 28 days before enrolment, or who plan to receive one during the study.
- People who have had major surgery or a serious physical injury within 4 weeks before starting treatment.
- People with conditions that may interfere with the body absorbing the study drug, such as severe vomiting, a blockage in the digestive system, or active bleeding or a perforation in the digestive tract.
- People with an active infection (bacterial, viral, or fungal) that is not controlled despite treatment.
- People who are known to have an allergy or sensitivity to any of the study drugs or their ingredients.
- People whom the treating doctor considers unsuitable for the study due to safety or other concerns.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Contact this trial
Phone: +86 13466323860
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Zhijie Wang
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 June 2027
Where this trial is recruiting
🇨🇳 China
Primary endpoints
Progression-Free Survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.